{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:1910ce15-708c-4419-b363-fbc53d28a433", "type": "composite", "version": "1", "versioncreated": "2026-08-24T06:03:15.777013Z", "firstcreated": "2026-08-24T06:03:15.777013Z", "pubstatus": "usable", "language": "uk", "headline": "Акції Hanmi Pharm зросли на 30% після угоди з Genentech про препарат проти ожиріння", "description_text": "Південнокорейська фармацевтична компанія Hanmi Pharm уклала ліцензійну угоду з американською Genentech щодо розробки інноваційного препарату для лікування ожиріння. Новина спричинила зростання акцій компанії на 30%.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:cc9d24c0-d312-4927-9272-80e05795b594", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-24T06:03:34.322402Z", "firstcreated": "2026-08-24T06:03:15.777013Z", "pubstatus": "usable", "urgency": 5, "language": "uk", "headline": "Акції Hanmi Pharm зросли на 30% після угоди з Genentech про препарат проти ожиріння", "byline": "Вадим Білик", "located": "Ukraine", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Контрактова", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Контрактова”. Set rel=canonical to https://kontraktova.com/biznes/aktsii-hanmi-pharm-zrosli-na-30-pislia-ugodi-z-genentech-pro-preparat-proti-ozhirinnia/ when publishing on the web.", "description_text": "Південнокорейська фармацевтична компанія Hanmi Pharm уклала ліцензійну угоду з американською Genentech щодо розробки інноваційного препарату для лікування ожиріння. Новина спричинила зростання акцій компанії на 30%.", "altids": {"mosaic": "cc9d24c0-d312-4927-9272-80e05795b594", "story": "1910ce15-708c-4419-b363-fbc53d28a433", "slug": "aktsii-hanmi-pharm-zrosli-na-30-pislia-ugodi-z-genentech-pro-preparat-proti-ozhirinnia"}, "subject": [{"name": "Economy and business", "rel": "direct", "literal": "economy", "code": "medtop:04000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/04000000"}], "place": [{"name": "Ukraine", "literal": "ua", "code": "UA", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:fbc42aed-be22-4b25-b053-d841dc1c3cdf", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "content-media.investing.com", "copyrightnotice": "content-media.investing.com", "usageterms": "No machine-readable licence: address and terms are delivered, the file is not.", "altids": {"wireva": "fbc42aed-be22-4b25-b053-d841dc1c3cdf"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "", "licence_verified_at": null, "attribution_required": true, "attribution_text": "content-media.investing.com", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "content-media.investing.com", "source_url": "https://content-media.investing.com/news/LYNXNPEB6R0AQ_M.jpg", "source_page_url": "https://content-media.investing.com/news/LYNXNPEB6R0AQ_M.jpg", "our_page_url": "https://kontraktova.com/biznes/aktsii-hanmi-pharm-zrosli-na-30-pislia-ugodi-z-genentech-pro-preparat-proti-ozhirinnia/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://content-media.investing.com/news/LYNXNPEB6R0AQ_M.jpg", "mimetype": ""}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:1910ce15-708c-4419-b363-fbc53d28a433", "slug": "hanmi-pharm-30-genentech-20260824", "status": "developing", "languages": ["uk"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Контрактова", "canonical_required": true, "canonical_url": "https://kontraktova.com/biznes/aktsii-hanmi-pharm-zrosli-na-30-pislia-ugodi-z-genentech-pro-preparat-proti-ozhirinnia/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_borderline", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Матеріал підготовлено за допомогою ШІ під редакційною відповідальністю Haydamax OÜ.", "independence_check": {"status": "borderline", "score": 0.444, "checked_at": "2026-08-24T06:03:34.330690Z"}, "sources": [{"url": "https://www.investing.com/news/stock-market-news/hanmi-pharm-shares-jump-30-on-genentech-obesity-drug-deal-93CH-4872635", "title": "Hanmi Pharm shares jump 30% on Genentech obesity drug deal", "publisher": "investing.com", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-24T06:03:34.325180Z", "published_at": "2026-08-24T04:16:46Z"}]}, "wireva:publication": {"name": "Контрактова", "domain": "kontraktova.com", "country": "UA", "url": "https://kontraktova.com/biznes/aktsii-hanmi-pharm-zrosli-na-30-pislia-ugodi-z-genentech-pro-preparat-proti-ozhirinnia/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/cc9d24c0-d312-4927-9272-80e05795b594", "html": "https://wireva.mib.news/item/cc9d24c0-d312-4927-9272-80e05795b594/aktsii-hanmi-pharm-zrosli-na-30-pislia-ugodi-z-genentech-pro-preparat-proti-ozhirinnia/", "story": "https://wireva.mib.news/story/hanmi-pharm-30-genentech-20260824/"}, "wireva:metrics": {"word_count": 390, "char_count": 3169, "reading_time_seconds": 226}}}}, "extra": {"wireva:languages": ["uk"], "wireva:status": "developing", "wireva:item_count": 1}}